← Back to Search

Behavioural Intervention

Single 10 minute session for Meibomian Gland Dysfunction

N/A
Waitlist Available
Led By Scott Hauswirth, MD
Research Sponsored by University of Colorado, Denver
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 60 days
Awards & highlights

Study Summary

This trial will study the effectiveness of the TearRestore eyelid warming mask on Meibomian Gland Dysfunction (MGD), a leading cause of dry eye symptoms. The study will investigate whether the TearRestore mask affects meibomian gland function and dry eye symptoms.

Eligible Conditions
  • Meibomian Gland Dysfunction

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 60 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 60 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Standardized Patient Evaluation of Eye Dryness (SPEED) Questionnaire
Secondary outcome measures
Lipid Layer Thickness
Number of Meibomian Glands Yielding Liquid Secretions
Tear Breakup Time

Trial Design

2Treatment groups
Experimental Treatment
Group I: Single 10 minute sessionExperimental Treatment1 Intervention
Study assessments will be performed before single 10 minute session of wearing the Tear Restore Mask and then study assessments will be repeated after the 10 minute single session has been completed.
Group II: Optional ExtensionExperimental Treatment1 Intervention
Subjects can choose to extend use of the Tear Restore Mask at home for a period of 28 to 60 days. They will use the mask for a 10 minute time period one time per day and record the use in a diary.

Find a Location

Who is running the clinical trial?

University of Colorado, DenverLead Sponsor
1,732 Previous Clinical Trials
2,143,533 Total Patients Enrolled
Scott Hauswirth, MDPrincipal InvestigatorUniversity of Colorado, Denver

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this experiment actively recruiting participants?

"According to the clinicaltrials.gov database, this particular medical trial has concluded its recruitment process and is no longer looking for participants. This research was first posted in November 2020 and updated for a final time on February 16th 2022. Nevertheless, there are 17 other studies actively recruiting patients at present."

Answered by AI

Who is the ideal population for this medical research?

"Those hoping to join this clinical trial must have meibomian gland dysfunction and meet the age criteria of 18-89. The study is seeking out approximately 50 participants."

Answered by AI

Is the trial available to seniors aged 60 and over?

"This medical trial has an upper limit of 89 years old and a lower limit of 18 for patient inclusion."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
The Effect of Warm Compress Therapy Using the TearRestore Eyelid Warming Mask on Meibomian Gland Function
2020. "The Effect of Warm Compress Therapy Using the TearRestore Eyelid Warming Mask on Meibomian Gland Function". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04309799.
~11 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top